N2S2 chelate-targeting ligand conjugates

Abstract

The invention provides, in a general sense, a new labeling strategy employing compounds that are N 2 S 2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angiogenesis targeting ligand, a tumor apoptosis targeting ligand, a …